Hereditary pheochromocytoma-paraganglioma
MONDO:0017366Neoplasm predisposition characterized by an increased risk of paragangliomas (tumors that arise from neuroendocrine tissues distributed along the paravertebral axis from the base of the skull to the pelvis) and pheochromocytomas (paragangliomas that are confined to the adrenal medulla).
Also known as: familial pheochromocytoma-paraganglioma, hereditary paraganglioma-pheochromocytoma syndrome, hereditary pheochromocytoma-paraganglioma, SDHx-related paraganglioma-pheochromocytoma, hereditary paraganglioma-pheochromocytoma
1487 clinical trials for this condition and its sub-types, 6 tagged with Hereditary pheochromocytoma-paraganglioma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Hereditary pheochromocytoma-paraganglioma
-
MAX-related tumor predisposition 0 trials
-
TMEM127-related tumor predisposition 0 trials
-
Hidden trigger? study probes whether common chemicals spark tumors in genetically vulnerable people
Knowledge-focused Recruiting nowThis study investigates whether exposure to certain chemicals found in the environment, home, or workplace can increase the risk of developing paraganglioma tumors in people who carry an inherited SDHx gene mutation. Researchers will compare chemical exposure histories between mu…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
Hunt for hidden cancer genes: families needed to unlock hereditary secrets
Knowledge-focused Recruiting nowThis study aims to discover new genes that may cause certain cancers to run in families. Researchers will collect blood samples and health information from 1,500 people in families where multiple members have had cancer, especially childhood cancers. The goal is to build a regist…
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC